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Abstract. Pigeons were trained to discriminate either a fixed 
dose of PCP (1 mg/kg; n =  3) or a progressively decreasing 
dose (1-0.56-0.32 mg/kg; n=4)  from saline. Lowering of 
the training dose shifted the dose-effect curve for PCP's 
discriminative stimulus effects about 5-fold to the left, in 
a parallel manner, but did not decrease the accuracy of 
the discrimination performance and did not significantly 
increase the extent to which pentobarbital and chlordiaze- 
poxide produced PCP-appropriate responding. Dose-effect 
curves based on binary generalization data were evaluated 
statistically with new methods that may be more appro- 
priate than those used previously. Metaphit, a proposed 
PCP-receptor acylator, and 2-amino-5-phosphonovalerate 
(AP5), an N-methyl-D-aspartate (NMDA) antagonist, pro- 
duced complete PCP-appropriate responding in the high 
training dose group only at doses that suppressed the rate 
of responding and that produced ataxia. However, 4-fold 
lower doses of metaphit and AP5, which did not produce 
directly observable behavioral effects, were found to substi- 
tute completely for PCP in the low training dose group. 
These data support the notion that PCP, metaphit, and 
AP5 have a common discriminative effect in pigeons. 
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Phencyclidine (PCP), a significant drug of abuse, has anti- 
convulsant effects (e.g., Chen et al. 1959), analgesic and 
anesthetic effects (e.g., Chen and Weston 1960), effects that 
resemble schizophrenia (e.g., Domino and Luby 1981), and 
anticonflict effects (e.g., Cook and Davidson 1973). Certain 
of these effects might result from a PCP receptor-mediated 
reduction of neurotransmission at excitatory synapses uti- 
lizing NMDA-preferring receptors (i.e., AAI receptors; 
Fagg et al. 1986). Recently, we reported behavioral evidence 
in support of this hypothesis: 2-amino-5-phosphonovaler- 
ate (AP5), a potent and highly selective N M D A  antagonist 
(Watkins and Evans 1981), produced PCP-like behavioral 
effects in pigeons and in rats (Koek et al. 1986a, b, 1987), 
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and may produce PCP-like behavioral effects in rhesus 
monkeys (Woods et al. 1986). However, the results of our 
study in pigeons (Koek et al. 1986b) suggested an impor- 
tant difference between AP5 and PCP: AP5 may produce 
PCP-like discriminative stimulus effects only at doses that 
greatly increase the key-selection latency and are very close 
to the cataleptic dose, unlike PCP. 
Metaphit, a derivative of PCP differing by the meta- 
phenyl substitution of an isothiocyanate group, specifically 
acylates PCP receptors in vitro (Rafferty et al. 1985) and 
in vivo (Contreras et al. 1986). Metaphit produced PCP-like 
stereotyped behavior and ataxia in some rats, leading Con- 
treras et al. (1986) to conclude that metaphit is a weak PCP 
agonist. In pigeons and in rhesus monkeys, metaphit pro- 
duced PCP-like agonist actions (Koek et al. 1985, 1986c). 
However, metaphit induced PCP-like discriminative stimu- 
lus effects in pigeons only at doses that greatly increased 
the key-selection latency and that were very close to the 
cataleptic dose, unlike PCP. 
Thus, PCP-like discriminative stimulus effects of AP5 
and metaphit were observed only at doses that also pro- 
duced other behavioural effects (i.e., ataxia and greatly in- 
creased latencies to select the PCP-appropriate key). The 
first aim of the present experiment was to characterize fur- 
ther the PCP-like discriminative stimulus of  AP5 and meta- 
phit: first, by studying the ability of these compounds to 
substitute for a training dose of PCP that was lowered pro- 
gressively from I to 0.32 mg/kg, and second, by comparing 
the results directly to data that were obtained previously 
with these compounds in pigeons in which i mg/kg PCP 
was used throughout as the traninig dose. In pigeons, discri- 
minative stimulus control that is induced by 1 mg/kg PCP 
is characterized by a high degree of accuracy and pharma- 
cological specificity (e.g., Herling et al. 1981; McMillan 
1982; Leander 1982). However, it has been suggested that 
the pharmacological specificity of a drug discrimination 
may be codetermined by the training dose (e.g., Colpaert 
et al. 1980). In particular, a lowering of the training dose 
may result in reduced pharmacological specificity and broa- 
dened stimulus generalization (i.e., "overinclusiveness", 
Overton 1974). Thus, a second objective of the present 
study was to investigate possible differences in the pharma- 
cological specificity of the discriminative stimulus proper- 
ties of different training doses of PCP. 
In drug discrimination, response selection is one of the 
currently used variables to measure discrimination and gen- 
eralization. In a drug-saline discrimination, response selec- 
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tion is a binary variable, i.e., selection of the saline response 
or selection of the drug response. When different doses are 
tested of a treatment that produces drug-appropriate re- 
sponding, the percentage of animals selecting the drug re- 
sponse can be plotted as a function of dose in log-linear 
coordinates. Analysis of these data by means of the method 
of Litchfield and Wilcoxon (1949) is not entirely appro- 
priate, as the data samples at different doses are obtained 
in the same subjects and are therefore not independent (Sto- 
lerman and D'Mello 1981). Appropriate methods for statis- 
tical analysis of these dose-effect curves for related samples 
do not seem to be available (Colpaert 1986). A third objec- 
tive of the present study was to explore a different approach 
to this problem, by using methods in which the lowest dose 
that produces selection of the drug response (i.e., threshold 
dose) was used as the basic datum for statistical analysis. 
Materials and methods 
Subjects. Eight experimentally naive White Carneaux pi- 
geons (Palmetto, Sumter, SC) were housed individually with 
water and grit freely available and were maintained at 80% 
of their free-feeding weight by providing mixed grain in 
the home cage after each experimental session. 
Apparatus. Six ventilated, sound-attenuated chambers mea- 
suring 36x 28 x 33 cm were used. Three translucent re- 
sponse keys, 2.4 cm in diameter, were located on the inside 
of one wall, 25 cm from the chamber floor. The keys were 
5 cm from each other and could be transilluminated by 
red 7 W lights located behind the wall. Mixed grain was 
made available for reinforcement by means of a hopper, 
below the center response key and 10 cm above the floor 
of the chamber. A Texas Instruments Inc. (Dallas, TX) 
960A computer, located in an adjacent room, was used 
for programming and data collection. 
Procedure. After autoshaping of a key-peck response, all 
pigeons were trained to discriminate an IM injection of 
1 mg/kg PCP from saline. Training sessions were conducted 
7 days/week. Each session was preceded by an injection of 
either PCP or saline, after which the pigeon was placed 
in the experimental chamber. After 10 min, during which 
the chamber was dark and key-peck responses had no pro- 
grammed consequences, the houselight came on and the 
left and the right key were illuminated red. During the first 
two to three sessions saline was administered and responses 
on the right key resulted in 4-s access to mixed grain, ac- 
cording to a reinforcement schedule that was gradually 
changed from fixed ratio (FR) I to FR 20. The key lights 
were off during food presentation and a white light illumi- 
nated the hopper. A session ended after 50 reinforcements, 
or after 1 h, whichever occurred first. During the next two 
to three sessions PCP was administered, responses on the 
left key were reinforced and the reinforcement schedule was 
changed from FR 1 to FR 20. Thereafter, drug and saline 
sessions alternated according to a double-alternation se- 
quence. Twenty responses on the injection-appropriate key 
(i.e., left key PCP-appropriate, right key saline-appropriate) 
resulted in reinforcement. Responses on the inappropriate 
key had no programmed consequences. Training was con- 
tinued until less than five responses were made on the injec- 
tion-inappropriate key, before the first food presentation, 
during ten consecutive sessions. When this training criterion 
was met, test sessions (T) and drug (D) and saline (S) train- 
ing sessions were conducted according to two, weekly alter- 
nating, sequences: S-D-T-S-T-D-T, D-S-T-S-T-D-T. A test 
session ended, without reinforcement, when 20 responses 
had been made on either key, or after 1 h, whichever oc- 
curred first. The key on which 20 responses accumulated 
first was defined as the selected key. 
Tests were conducted only if the injection-appropriate 
key was selected during both the immediately preceding 
drug training session and saline training session, otherwise 
drug and saline training sessions were alternated until the 
appropriate key was selected during two consecutive ses- 
sions. 
Different doses of PCP were tested in all eight pigeons. 
Thereafter, the training dose of PCP was decreased from 
I to 0.56 mg/kg, in five pigeons. After these pigeons met 
the discrimination criterion at the lowered training dose, 
different doses of PCP were tested and the training dose 
was reduced further to 0.32 mg/kg. Both the pigeons that 
met the discrimination criterion when 0.32 mg/kg PCP was 
used as the training dose (n = 4) and the pigeons for which 
the training dose remained at 1 mg/kg (n = 3), were tested 
with PCP, metaphit, AP5, pentobarbital and chlordiazepox- 
ide. The injection-test interval was 1 h for metaphit, 30 rain 
for AP5 and ~ 0 rain for the other drugs. 
Data analysis. The percentage of PCP-key selections was 
used as a measure of PCP-like discriminative stimulus ef- 
fects. The lowest dose that produced selection of the PCP 
key (generalization threshold dose) was determined for each 
subject, for each drug. The geometric mean threshold dose 
was used as a measure of the drug's potency. Drug potencies 
can best be compared if the dose-effect curves are parallel. 
The slope of the curve relating log-dose with percentage 
of PCP-key selections is a function of the variance of the 
log-threshold doses; as this variance increases, the slope 
becomes less steep. Thus, parallelism of dose-effect curves 
may be evaluated by testing for homogeneity of the vari- 
ances of the log-threshold doses. However, tests for homo- 
geneity of variance may not have a high degree of sensitivity 
(e.g., Winer 1971). Therefore, a different approach was 
taken to evaluate parallelism of dose-effect curves: a line 
was fitted by linear regression to log dose-effect data for 
each drug and the statistical significance of slope differences 
was assessed, using the methods described by Tallarida and 
Murray (1981). 
Selection latency was defined as the time between the 
illumination of the response keys and the occurrence of 
key selection. Selection latencies were log-transformed prior 
to statistical analysis. 
Data were analyzed by one-factor repeated measures 
ANOVA and by two-factor ANOVA with repeated mea- 
sures on one factor (Winer 1971). Post-hoc comparisons 
were made using Dunnett's t-test. A likelihood ratio Chi- 
square test (Everitt 1977) was used to analyze effects of 
different training doses on the maximum percentage of 
PCP-key selections produced by drugs that failed to induce 
100% PCP-key selection. For each drug, a 2 x 2 contingen- 
cy table was constructed with the following cell entries: 
maximum number of pigeons, trained with 1 mg/kg PCP, 
that selected the PCP key; remaining number of similarly 
trained pigeons that selected the saline key; maximum 
number of pigeons, trained with 0.32 mg/kg PCP, that se- 
lected the PCP key; remaining number of similarly trained 
% PCP- KEY 
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pigeons that selected the saline key. The degree of hetero- 
geneity in each contingency table was calculated by means 
of likelihood ratio Chi-square (see Robbins 1977 for a 
worked example). 
Drugs. The compounds used were phencyclidine hydrochlo- 
ride (Warner-Lambert/Parke-Davis and Co., Ann Arbor, 
MI), metaphit (1-[1-(3-isothiocyanatophenyl)cyclohexyl]pi- 
peridine) methanesulphonate (provided by Dr. A.E. Jacob- 
son and Dr. K.C. Rice, National Institutes of Health, Beth- 
esda, MD), DL-2-amino-5-phosphonovalerate (AP5) hydro- 
chloride (Sigma Chemical Co., St. Louis, MO), pentobarbi- 
tal sodium (Gaines Chemical Works, New York, NY) and 
chlordiazepoxide hydrochloride (Hoffmann-La Roche, 
Nutley, NJ). AP5 was dissolved in a minimum quantity 
of 1 N NaOH, to which sterile water was added. All other 
drugs were dissolved in sterile water. Doses of PCP are 
expressed as the free base; doses of all other drugs are 
expressed in the forms described above. 
Results 
PCP (1 mg/kg) acquired discriminative control over re- 
sponding in all pigeons; the geometric mean of the number 
of sessions to criterion (GM-STC) was 28.9. All five pigeons 
for which the training dose was decreased to 0.56 mg/kg 
PCP met the discrimination criterion at a GM-STC value 
of 8.1. Four out of these five pigeons reached criterion 
at a training dose that was decreased further to 0.32 mg/kg 
(GM-STC=40.1);  one pigeon failed to meet the criterion 
within 100 sessions and was thereupon excluded from the 
study. 
The accuracy of the post-criterion discrimination per- 
formance was not significantly different between the three 
pigeons that were trained with 1.0 mg/kg PCP and the four 
pigeons that were trained with 0.32 mg/kg PCP [F(1,5)= 
0.86], but was significantly higher during saline sessions 
than during drug sessions [F(1,5)=13.43, P<0.02];  the 
mean percentage of correct key selections (_+ 1 SEM) was 
95+2  during saline sessions and was 84_+3 during drug 
sessions. This effect of type of training session (drug or 
saline) was not significantly different at the two training 
dose levels [F(1,5)= 0.03]. 
At each training dose, PCP exerted dose-dependent ef- 
fects on the percentage of PCP-key selections (Fig. 1). The 
log dose-key selection data obtained at each training dose 
could be fitted adequately by straight lines; the correlation 
coefficients (r) ranged from 0.89 to 1.0. The slopes of these 
lines were not significantly different (P>0.05);  the overall 
slope value, indicating the amount by which the percentage 
of drug-key selections increased per 1 log unit increase of 
dose, was 143. The training dose significantly affected the 
geometric mean threshold dose (GM-TD) [F(2,6)=15.66, 
P<0.001]; GM-TD was 0.75 mg/kg at a training dose of 
1 mg/kg and was significantly lower (i.e., 0.37 mg/kg) at 
a training dose of 0.56 mg/kg (P < 0.05). Further, GM-TD 
was 0.16 mg/kg at a training dose of 0.32 mg/kg, a value 
that is significantly lower than the value obtained at a train- 
ing dose of 0.56 mg/kg (P<0.01).Thus, reducing the train- 
ing dose from 1.0 to 0.32 mg/kg produced a 4.8-fold reduc- 
tion of the geometric mean threshold dose, indicating that 
the potency of PCP increased about 5-fold. PCP did not 
significantly affect the mean key selection latency [F(4,12)< 








I I I I I 
0.1 0.32 I 
PCP 
439 
Fig. 1. Discriminative stimulus effects of PCP m pigeons (n = 3) 
trained to discriminate between IM injections of PCP and of saline. 
The training dose of PCP was lowered progressively from 1 to 
0.32 mg/kg and a dose-effect curve was established at each training 
dose level, in pigeons (n = 4) that met the discrimination criterion 
at all training doses. Ordinate: percentage of PCP-key selections; 
abscissa: IM dose administered (mg per kg). Training dose e-e  
1 ~ -~056o  o0.32 
AP5 and metaphit produced PCP-appropriate respond- 
ing (Fig. 2), in all pigeons that were trained with 1 mg/kg 
PCP and in all pigeons that were trained with 0.32 mg/kg 
PCP. The dose-effect data obtained with PCP, AP5 and 
metaphit, at both training dose levels, could be fitted ade- 
quately (the value of r ranged from 0.86 to 1.0) by straight 
lines, that did not deviate significantly from parallelism 
(P>0,05;  overall slope value: 139). Analysis of the log- 
threshold doses of PCP, AP5 and metaphit at both training 
doses showed a statistically significant effect of training 
dose [F(1,5)=33.10, P<0.005], a significant effect of test 
drug [F(2,10)=151.57, P<0.001] and a non-significant 
training dose x test drug interaction [F(2,10)=0.13]. PCP 
was significantly more potent than metaphit (P < 0.01) and 
than AP5 (P<0.01). PCP was about 40 times more potent 
than metaphit and about 230 times more potent than AP5, 
irrespective of the training dose of PCP. Further, PCP, me- 
taphit, and AP5 were about four times more potent in the 
group that was trained with 0.32 mg/kg PCP than in the 
group that was trained with 1 mg/kg PCP. 
However, the effects of metaphit and AP5 on key selec- 
tion latency did not appear to vary as a function of the 
training dose of PCP. Both metaphit and AP5 induced 
1 mg/kg-PCP appropriate responding at doses that signifi- 
cantly increased the key-selection latency ( P <  0.01, in both 
cases). The geometric mean latency was increased from 
10.9 s to 2105.4 s by 38 mg/kg metaphit and to 1871 s by 
180 mg/kg AP5. Moreover, at these doses ataxia was evi- 
dent in the pigeons upon their removal from the experimen- 
tal chambers after the session had ended. 
In pigeons that were trained with 0.32 mg/kg PCP, me- 
taphit failed to significantly affect key-selection latency 
[F(4,12)=0.67] and AP5 significantly increased key-selec- 
tion latency only at a dose of 100 mg/kg (P<0.01). This 
dose of AP5 was higher than the dose that induced PCP- 
appropriate responding in all animals (i.e., 56 mg/kg). Fur- 
ther, ataxia did not occur at doses of metaphit and AP5 
that induced 0.32 mg/kg-PCP appropriate responding in all 
animals. Thus, it should be noted that metaphit and AP5 
produced PCP-appropriate responding at doses that pro- 
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Fig. 2. Discriminative stimulus effects of PCP, AP5, metaphlt, pentobarbital and chlordiazepoxide in pigeons (n = 3) trained to discriminate 
between injections of 1 mg/kg PCP and of saline, and in pigeons (n=4) trained to discriminate between injections of 0.32 mg/kg PCP 
and of saline. Data points that are marked with a "'a" were obtained at doses that significantly increased the mean key-selection 
latency. Ordinates: percentage of PCP-key selectaons: abscissae: IM dose administered (mg per kg). Dose-response curves of AP5 and 
of metaphit in pigeons that were trained with a dose of I mg/kg PCP are replotted from other sources (Koek et al. 1985, 1986b). 
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duced neither direct effects on key selection latency nor 
ataxia. 
Neither pentobarbital nor chlordiazepoxide produced 
PCP-appropriate responding in all animals, at both training 
doses of PCP (Fig. 2). Further, the maximum effect pro- 
duced by these drugs, measured as the percentage of pigeons 
that selected the PCP key, was not significantly different 
in pigeons that were trained with 0.32 mg/kg PCP than 
in pigeons that were trained with 1 mg/kg PCP (the value 
of chi-square with 1 degree of freedom equalled 0.06 for 
pentobarbital and 1.24 for chlordiazepoxide; P>0.20 in 
both cases). Pentobarbital (10mg/kg) significantly in- 
creased key-selection latency from 8.9 to 51.3 s in the high 
training dose group (P<0.05) and to 380.2 s in the low 
training dose group (P<0.01); 18 mg/kg suppressed re- 
sponding completely. Chlordiazepoxide significantly in- 
creased key-selection latency in both training dose groups: 
the latency was increased to 40.7 s by 10 mg/kg chlordiaze- 
poxide (P<0.05) and to 1047.1 s by 18 mg/kg (P<0.01) 
in the high training dose group. In the low training dose 
group, 10 mg/kg chlordiazepoxide increased the selection 
latency to 602.6 s (P<0.05); the animals failed to select 
either key during the 60 rain session after 18 mg/kg chlor- 
diazepoxide. 
Discussion 
The lowering of the training dose of PCP from 1 to 0.32 mg/ 
kg PCP shifted the generalization curve about 5-fold to 
the left, in a parallel manner (see also Beardsley et al. 1987). 
Further, neither the accuracy of the post-criterion discrimi- 
nation performance nor the pharmacological specificity of 
the discrimination was significantly affected by the progres- 
sive lowering of the training dose. Thus, an assay of PCP- 
like discriminative stimulus effects was obtained that was 
more sensitive but neither less accurate nor less pharmaco- 
logically specific. AP5 and metaphit were found to substi- 
tute completely for PCP, both when a high and when a 
progressively lowered training dose of PCP was used. Fur- 
ther, AP5 and metaphit substituted completely for 0.32 mg/ 
kg PCP at doses that were about 4-fold lower than the 
doses of these drugs that substituted for 1 mg/kg PCP. At 
these lower doses, AP5 (56 mg/kg) and metaphit (10 mg/kg) 
neither increased the latency to select the PCP-appropriate 
key, nor produced ataxia. These results suggest that AP5 
and metaphit may produce discriminative stimulus effects 
at doses that are at least 5-fold lower than the doses at 
which these drugs produce PCP-like catalepsy (catalepsy 
is induced in all subjects by 320 mg/kg AP5 and by 66 rag/ 
kg metaphit; Koek et al. 1985, 1986b). That these discri- 
minative stimulus effects are indeed PCP-like is suggested 
by the finding that the pharmacological specificity of the 
PCP discrimination did not appear to be diminished by 
the progressive lowering of the training dose, Thus, the 
findings of the present study suggest that both AP5 and 
metaphit may produce PCP-like effects at doses that are 
substantially lower than the cataleptic dose and that do 
not produce directly observable behavioral effects. 
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In some drug classes, low training doses may be asso- 
ciated with a lower degree of  pharmacological  specificity 
(e.g., Overton 1984). Because of  the substantial  amount  
of  cross-generalization between PCP and pentobarbi ta l  
(e.g., Overton 1975; McMil lan  and Wenger  1983), the use 
of  pentobarb i ta l  as a test drug in the present study would 
appear  to offer a strong test of  a possible reduction of  
the pharmacological  specificity of  the PCP discrimination. 
However,  evidence for such a reduction was not  obtained.  
Thus, a lowering o f  the training dose of  PCP does not  
necessarily produce a lowered specificity. The lowering of  
the training dose of  PCP shifted the generalization curve 
in a parallel  manner.  I t  may be that  a reduction of  the 
pharmacological  specificity will be obtained only when the 
generalization curve flattens as the training dose is lowered 
further. 
In the present study, complete dose-effect curves or gen- 
eralization gradients that  were based on binary generaliza- 
t ion data,  were analyzed by performing analyses o f  variance 
on threshold-dose values. This method was sensitive to dif- 
ferences in the posi t ion of  the dose-effect curves on the 
dose-axis;  thus, it may provide an appropr ia te  alternative 
to the method of  Litchfield and Wilcoxon for the analysis 
of  potency differences. F o r  dose-effect curves that  are based 
on binary generalization data,  an entirely appropr ia te  anal- 
ysis of  slope differences may still present a p roblem;  tests 
of  homogenei ty of  variances of  threshold doses may be 
less sensitive than the methods  described by Tal lar ida and 
Murray.  However,  the lat ter  methods assume that  the da ta  
samples obtained at different doses are independent.  Evi- 
dence for a greater sensitivity of  the methods described 
by Tal lar ida and Mur ray  may  be provided by the following 
hypothetical  example:  three linear dose-effect curves, that  
described the relation between log-dose and percentage of  
animals that  selected the drug-appropr ia te  key (n = 4), were 
constructed such that  the dose that  p roduced  0% drug-key 
selection and the doses that  produced 100% drug-key selec- 
tion were either 2 log-units (curve 1), 1 log-unit  (curve 2), 
or 0.5 log-unit  (curve 3) apart .  Each curve was based on 
five data  points  (0%, 25%, 50%, 75% and 100% drug 
key selection). Homogenei ty  tests of  the variances of  the 
log-threshold doses showed a significant difference between 
the da ta  comprising curve 1 and curve 3 [F(3.3)= 15.88, P <  
0.05]; however, curve 2 was not  significantly different from 
either curve 1 or  curve 3 (P>0.10) .  An  analysis by means 
of  the methods described by Tal lar ida and Mur ray  showed 
the slope values of  the three curves (50, 100, and 200, for 
curve 1, 2, and 3, respectively) to be significantly different 
from one another  (curve 1 - c u r v e  2: Student 's  t =  73.3, df= 
6, P < 0 . 0 0 1 ;  curve l - c u r v e  3: t=101.5,  df=6, P < 0 . 0 0 1 ;  
curve 2 - c u r v e  3: t =  52.9, df=6, P<0.001) .  
N M D A  antagonists  have been proposed  as having ther- 
apeutic potent ial  as anticonvulsants  (e.g., Meldrum 1985) 
and as anxiolytics (Bennett et al. 1985, 1986; Stephens et al. 
1986). The present s tudy offers further evidence of  PCP-like 
behavioral  effects of  AP5, an N M D A  antagonist .  In addi- 
tion, the results suggest that  these PCP-like effects may 
not  be restricted to sedating doses of  AP5. Therefore, they 
make it even more relevant to evaluate PCP-like behavioral  
activity in trials of  N M D A  antagonists  as potent ial  anticon- 
vulsants and anxiolytics. 
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